References
- Arend WP, Dayer JM . Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990;33:305–15.
- Jouvenne P, Fossiez F, Garrone P, Djossou O, Banchereau J, Miossec P. Increased incidence of neutralizing autoantibodies against interleukin- la (IL-1a) in non-destructive chronic polyarthritis. J Clin Immunol 1996;16: 283–90.
- Jouvenne P, Fossiez F, Banchereau J, Miossec P. High levels of neutralising autoantibodies against IL-la are associated with better prognosis in chronic polyarthritis: a follow up study. Scand J Immunol 1997;46:413–8
- Svensson B, Schauffelberger C, Teleman A, Theander J. Remission and response to early treatment of rheumatoid arthritis assessed by Disease Activity Score. Rheumatology 2000;39:1031–6.
- Svenson M, Hansen MB, Bendtzen K. Distribution and charac-terisation of autoantibodies to interleukin-la in normal human sera. Scand J Immunol 1990;32:695–701.
- Dale K. Radiographic damage assessment: the method and technique. Rheumatology in Europe 1994;23:136–41.
- Van Gestel AM, Haagsma CJ, van Riel PLCM. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 1998;41:1845–50.
- Ekdahl C, Eberhardt K, Andersson I, Svensson B. Assessing disability in patients with rheumatoid arthritis. Scand J Rheumatol 1988;17:263–71.
- Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137–45.